Lument Finance Trust (LFT) Q2 2026 Earnings Report

The call presented a mixed picture: management highlighted improving portfolio credit metrics (higher percentage of loans rated 3 or better), active asset resolutions, selective new originations, and a well-positioned financing profile (CLO deployment). However, material near-term headwinds dominated the quarter — GAAP and distributable losses, a sizable $8.6M credit provision, realized losses, an ~11.5% contraction in portfolio UPB, declining book value per share (~7.1% sequential), a concentrated set of troubled loans (≈$98M) and low REO occupancy (~67%). While management outlined clear remediation actions (asset resolutions, redeployment plans and a reverse split to improve marketability) and expects to be fully deployed in 2027, the near-term financial deterioration and continued asset stress weigh heavily on outlook.

The company reiterated guidance to prioritize active asset resolution, protect book value and redeploy capital efficiently with an objective to be fully invested in 2027 and said it expects several additional resolutions over the next quarter or two; key metrics disclosed include Q2 GAAP net loss of $0.18 per share and distributable loss of $0.10 per share, a declared quarterly dividend of $0.04, Q2 net interest income of $4.5M (down from $5.7M), total operating expenses of $3.9M, an $8.6M net provision for credit losses and $5.1M of realized losses (plus $390k REO depreciation), specific reserves of $7.4M (~18% of associated UPB), ending portfolio UPB of ~ $1.0B (from $1.13B), 51 floating-rate loans with a weighted average coupon ~704 bps (down from 709 bps) and a weighted average floating spread of 330 bps over SOFR, weighted average remaining term ~18 months, 100% indexed to 1‑month SOFR and 91.7% multifamily, six risk-rated-5 loans totaling $98M (~10% of UPB), REO of 4 properties carrying ~$61.6M with ~67% occupancy, CLO capital substantially deployed at an 88% advance rate with cost of funds SOFR+1.91, warehouse financing at a 68% effective advance and SOFR+209 bps, unrestricted cash of $29M, total book equity of ~$205M and common book value of ~$145M or $2.76 per share (down from $2.97), and a Board‑approved 10‑for‑1 reverse split effective Sept. 9 to support an orderly market for the stock.